Search for: "ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC" Results 21 - 40 of 51
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2013, 10:45 am by Bexis
Ortho-McNeil-Janssen Pharmaceuticals, 2013 WL 3480286 (Pa. [read post]
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]
27 Jul 2012, 12:40 pm by Bexis
Cephalon, Inc., 2010 WL 1257790, at *6 (D.N.J. [read post]
17 Feb 2012, 11:29 am by Bexis
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
26 Dec 2011, 1:02 am by Victoria VanBuren
Ortho-McNeil-Janssen Pharmaceuticals, Inc. , No. 11-2070 (7th Cir. [read post]
3 Oct 2011, 9:28 pm by Barry Barnett
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 11-2070 (7th Cir. [read post]
21 Jun 2011, 6:00 am by Mark Zamora
Ortho-McNeil-Janssen Pharmaceuticals Inc. announced that the lot of about 16,000 bottles of 3-milligram Risperdal tablets was shipped out anywhere from August, 2010  and February, 2011. [read post]
13 Jun 2011, 5:32 pm by FDABlog HPM
Paliperidone FDA approved INVEGA on December 19, 2006 under NDA No. 21-999 and granted the sponsor, Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984).  [read post]
23 May 2011, 9:59 pm by Patent Docs
Impax Laboratories, Inc. et al. 1:11-cv-00395; filed May 5, 2011 in the District Court of Delaware • Plaintiffs: Alza Corp.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. • Defendants: Impax Laboratories, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
4 May 2011, 7:52 am by Tron Emptage
His 20-year plus experience in pharmaceutical and managed care defines him as a key player in moving the company forward in the arena of national pharmaceutical managed care. [read post]
18 Apr 2011, 1:12 pm by Mark Zamora
Ortho-McNeil Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced it is voluntarily recalling two lots of TOPAMAX® (topiramate) 100mg Tablets.   [read post]
18 Apr 2011, 12:40 pm by Tom Lamb
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com)In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more commonly called the "package insert" or "label") for its Ortho Evra (norelgestromin/ ethinyl estradiol) transdermal system to give a stronger warning about blood clot related side effects like… [read post]
28 Jun 2010, 3:50 am by Steve McConnell
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2181 (Phila. [read post]
29 Apr 2010, 2:06 am by Ben Vernia
The Department of Justice announced on April 29 that Ortho-McNeil Pharmaceutical, LLC, and Ortho-McNeil-Janssen Pharmaceuticals, Inc., two subsidiaries of Johnson & Johnson, have agreed to pay $81 million to settle charges brought in two whistleblower suits that they violated the False Claims Act by promoting Topamax for off-label (unapproved) uses. [read post]
23 Feb 2010, 9:01 pm by Patent Docs
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/8: Alza Corporation and Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]